212 related articles for article (PubMed ID: 29725750)
1. Characterization of the endolysosomal system in human chordoma cell lines: is there a role of lysosomes in chemoresistance of this rare bone tumor?
Kolb-Lenz D; Fuchs R; Lohberger B; Heitzer E; Meditz K; Pernitsch D; Pritz E; Groselj-Strele A; Leithner A; Liegl-Atzwanger B; Rinner B
Histochem Cell Biol; 2018 Jul; 150(1):83-92. PubMed ID: 29725750
[TBL] [Abstract][Full Text] [Related]
2. Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A.
Lu Y; Dong S; Hao B; Li C; Zhu K; Guo W; Wang Q; Cheung KH; Wong CW; Wu WT; Markus H; Yue J
Autophagy; 2014; 10(11):1895-905. PubMed ID: 25483964
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine overcomes resistance of lung carcinoma cells to the dual PI3K/mTOR inhibitor PI103 by lysosome-mediated apoptosis.
Enzenmüller S; Gonzalez P; Debatin KM; Fulda S
Anticancer Drugs; 2013 Jan; 24(1):14-9. PubMed ID: 23111416
[TBL] [Abstract][Full Text] [Related]
4. [Morphological characteristics, especially the malignant features, of chordoma in comparison with the notochord].
Miyauchi M; Maruyama K
Gan No Rinsho; 1988 Aug; 34(9):1089-95. PubMed ID: 3172514
[TBL] [Abstract][Full Text] [Related]
5. The effects of chemotherapeutic agents on differentiated chordoma cells.
Bayrak OF; Aydemir E; Gulluoglu S; Sahin F; Sevli S; Yalvac ME; Acar H; Ozen M
J Neurosurg Spine; 2011 Dec; 15(6):620-4. PubMed ID: 21905773
[TBL] [Abstract][Full Text] [Related]
6. Indomethacin Disrupts Autophagic Flux by Inducing Lysosomal Dysfunction in Gastric Cancer Cells and Increases Their Sensitivity to Cytotoxic Drugs.
Vallecillo-Hernández J; Barrachina MD; Ortiz-Masiá D; Coll S; Esplugues JV; Calatayud S; Hernández C
Sci Rep; 2018 Feb; 8(1):3593. PubMed ID: 29483523
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
Gao M; Xu Y; Qiu L
J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
[TBL] [Abstract][Full Text] [Related]
8. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
Shalaby A; Presneau N; Ye H; Halai D; Berisha F; Idowu B; Leithner A; Liegl B; Briggs TR; Bacsi K; Kindblom LG; Athanasou N; Amary MF; Hogendoorn PC; Tirabosco R; Flanagan AM
J Pathol; 2011 Feb; 223(3):336-46. PubMed ID: 21171079
[TBL] [Abstract][Full Text] [Related]
9. Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells.
Yu L; Wu WK; Gu C; Zhong D; Zhao X; Kong Y; Lin Q; Chan MT; Zhou Z; Liu S
Oncotarget; 2016 Mar; 7(12):14693-707. PubMed ID: 26910910
[TBL] [Abstract][Full Text] [Related]
10. Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells.
Jahanafrooz Z; Stallinger A; Anders I; Kleinegger F; Lohberger B; Durchschein C; Bauer R; Deutsch A; Rinner B; Kretschmer N
Phytomedicine; 2018 Oct; 49():32-40. PubMed ID: 30217260
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis.
Zhitomirsky B; Assaraf YG
Oncotarget; 2017 Jul; 8(28):45117-45132. PubMed ID: 28187461
[TBL] [Abstract][Full Text] [Related]
12. Induction of lysosomal dilatation, arrested autophagy, and cell death by chloroquine in cultured ARPE-19 cells.
Yoon YH; Cho KS; Hwang JJ; Lee SJ; Choi JA; Koh JY
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):6030-7. PubMed ID: 20574031
[TBL] [Abstract][Full Text] [Related]
13. Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363.
Lamoureux F; Thomas C; Crafter C; Kumano M; Zhang F; Davies BR; Gleave ME; Zoubeidi A
Clin Cancer Res; 2013 Feb; 19(4):833-44. PubMed ID: 23258740
[TBL] [Abstract][Full Text] [Related]
14. Lysosomes as mediators of drug resistance in cancer.
Zhitomirsky B; Assaraf YG
Drug Resist Updat; 2016 Jan; 24():23-33. PubMed ID: 26830313
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of improved lysomotropic autophagy inhibitors.
Wang T; Goodall ML; Gonzales P; Sepulveda M; Martin KR; Gately S; MacKeigan JP
J Med Chem; 2015 Apr; 58(7):3025-35. PubMed ID: 25793774
[TBL] [Abstract][Full Text] [Related]
16. Chordoma.
Hueng DY; Ma HI; Sytwu HK
J Neurosurg Spine; 2013 May; 18(5):533-4. PubMed ID: 23414004
[No Abstract] [Full Text] [Related]
17. Response. Chordoma.
Bayrak OF; Gulluoglu S; Aydemir E
J Neurosurg Spine; 2013 May; 18(5):534. PubMed ID: 23776939
[No Abstract] [Full Text] [Related]
18. Expression of E-cadherin in chordomas: diagnostic marker and possible role of tumor cell affinity.
Mori K; Chano T; Kushima R; Hukuda S; Okabe H
Virchows Arch; 2002 Feb; 440(2):123-127. PubMed ID: 11964040
[TBL] [Abstract][Full Text] [Related]
19. Development of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies.
Bozzi F; Manenti G; Conca E; Stacchiotti S; Messina A; Dagrada G; Gronchi A; Panizza P; Pierotti MA; Tamborini E; Pilotti S
Neuro Oncol; 2014 Jan; 16(1):72-80. PubMed ID: 24366975
[TBL] [Abstract][Full Text] [Related]
20. Identification of repurposed small molecule drugs for chordoma therapy.
Xia M; Huang R; Sakamuru S; Alcorta D; Cho MH; Lee DH; Park DM; Kelley MJ; Sommer J; Austin CP
Cancer Biol Ther; 2013 Jul; 14(7):638-47. PubMed ID: 23792643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
